Alembic Pharmaceuticals received USFDA approval for its Sumatriptan injection, a generic equivalent for treating migraines and cluster headaches. This marks Alembic's first drug device combination.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback